These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6418181)

  • 61. Interaction of tri-O-methyl-beta-cyclodextrin with drugs. II. Enhanced bioavailability of ketoprofen in rats when administered with tri-O-methyl-beta-cyclodextrin.
    Nakai Y; Yamamoto K; Terada K; Horibe H; Ozawa K
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3745-7. PubMed ID: 6671012
    [No Abstract]   [Full Text] [Related]  

  • 62. Pharmacokinetic study of ketoprofen (19.583 R.P.) in man using the tritiated compound.
    Delbarre F; Roucayrol JC; Amor B; Ingrand J; Bourat G; Fournel J; Courjaret J
    Scand J Rheumatol Suppl; 1976; 1976(0):45-52. PubMed ID: 1068515
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ketoprofen extended-release capsules: a new formulation for the treatment of osteoarthritis and rheumatoid arthritis.
    Schumacher HR
    Clin Ther; 1994; 16(2):145-59. PubMed ID: 8062310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of various dosage of ketoprofen salt suppositories in acute inflammatory disease in infants (3-36 month old) and children (3-13 year old)].
    Carnelli VE; Mei VA; Cera R; Clemente E; Previtali M
    Minerva Pediatr; 1995 May; 47(5):199-205. PubMed ID: 7643821
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diffusion of intramuscular ketoprofen into the cerebrospinal fluid.
    Netter P; Lapicque F; Bannwarth B; Tamisier JN; Thomas P; Royer RJ
    Eur J Clin Pharmacol; 1985; 29(3):319-21. PubMed ID: 4076328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Use of the NSAID ketoprofen lysine salt in glucose-6-phosphate dehydrogenase (G6PD) deficiency in inflammatory disease in children].
    Corda R; Carnelli V
    Pediatr Med Chir; 1996; 18(4):391-4. PubMed ID: 9064672
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Piascledin in the treatment of chronic dorsalgia].
    Merkulova DM; Onsin AA; Merkulov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(9):18-22. PubMed ID: 24107875
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Faecal blood loss during administration of acetylsalicylic acid, ketoprofen and two new ketoprofen sustained-release compounds.
    Ranløv PJ; Nielsen SP; Bärenholdt O
    Scand J Rheumatol; 1983; 12(3):280-4. PubMed ID: 6604940
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetic characteristics of ketoprofen suppositories.
    Caillé G; Besner JG; Lacasse Y; Vézina M
    Biopharm Drug Dispos; 1980; 1(4):195-201. PubMed ID: 7448348
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of ketoprofen lysine salt on mucosa of rat stomach after ethyl alcohol intoxication.
    Kuczyńska J; Nieradko-Iwanicka B
    Biomed Pharmacother; 2021 Sep; 141():111938. PubMed ID: 34328086
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Single and multiple dose pharmacokinetics of enteric coated ketoprofen: effect of cimetidine.
    Verbeeck RK; Corman CL; Wallace SM; Herman RJ; Ross SG; Le Morvan P
    Eur J Clin Pharmacol; 1988; 35(5):521-7. PubMed ID: 3234462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Comparative open multicenter study of 2 kinds of oral administration of ketoprofen].
    Bitar N; Docquier C; Dubois JL; Gustin R; Halleux R; Siquet L; Caloine R; Mercier J
    Acta Belg Med Phys; 1985; 8(4):225-31. PubMed ID: 2937253
    [No Abstract]   [Full Text] [Related]  

  • 74. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
    Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
    Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics and relative bioavailability after single dose administration of 25 mg ketoprofen solution as compared to tablets.
    Stiegler S; Birkel M; Jost V; Lange R; Lücker PW; Wetzelsberger N
    Methods Find Exp Clin Pharmacol; 1995 Mar; 17(2):129-34. PubMed ID: 7674700
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet.
    Wei Q; Yang F; Luan L
    Drug Dev Ind Pharm; 2013 Jun; 39(6):928-34. PubMed ID: 22401710
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Linear pharmacokinetics of orally administered fenoprofen calcium.
    Nash JF; Bechtol LD; Bunde CA; Bopp RJ; Farid KZ; Spradlin CT
    J Pharm Sci; 1979 Sep; 68(9):1087-90. PubMed ID: 501526
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Highly sensitive determination of ketoprofen in human serum and urine and its application to pharmacokinetic study.
    Oka K; Aoshima S; Noguchi M
    J Chromatogr; 1985 Dec; 345(2):419-24. PubMed ID: 4086611
    [No Abstract]   [Full Text] [Related]  

  • 79. Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):305-16. PubMed ID: 3508191
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ketoprofen lysine salt inhibits disuse-induced osteopenia in a new non-traumatic immobilization model in the rat.
    Fiorentino S; Melillo G; Fedele G; Clavenna G; D'Agostino C; Mainetti E; Caselli GF
    Pharmacol Res; 1996; 33(4-5):277-81. PubMed ID: 8938021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.